CHEBI:90919 - Technivie

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name Technivie
ChEBI ID CHEBI:90919
Definition A mixture composed of ombitasvir, paritaprevir and ritonavir which is used for treatment of genotype 4 chronic hepatitis C virus infection without cirrhosis.
Stars This entity has been manually annotated by the ChEBI Team.
Roles Classification
Biological Role(s): antiviral drug
A substance used in the prophylaxis or therapy of virus diseases.
hepatitis C protease inhibitor
An inhibitor of hepatitis C protease, an enzyme required for production of proteins needed for viral assembly.
Application(s): antiviral drug
A substance used in the prophylaxis or therapy of virus diseases.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing Technivie (CHEBI:90919) has part ombitasvir (CHEBI:85183)
Technivie (CHEBI:90919) has part paritaprevir (CHEBI:85188)
Technivie (CHEBI:90919) has part ritonavir (CHEBI:45409)
Technivie (CHEBI:90919) has role antiviral drug (CHEBI:36044)
Technivie (CHEBI:90919) has role hepatitis C protease inhibitor (CHEBI:64924)
Technivie (CHEBI:90919) is a mixture (CHEBI:60004)
Synonyms Sources
Ombitasvir - paritaprevir -ritonavir mixt KEGG DRUG
Ombitasvir / paritaprevir / ritonavir ChemIDplus
Ombitasvir and paritaprevir and ritonavir ChemIDplus
Ombitasvir mixture with paritaprevir and ritonavir ChemIDplus
Brand Name Source
Technivie KEGG DRUG
Manual Xref Database
D10745 KEGG DRUG
View more database links
Citations Waiting for Citations Types Sources
26535020 PubMed citation Europe PMC
26583608 PubMed citation Europe PMC
26681900 PubMed citation Europe PMC
Last Modified
12 January 2016
General Comment
2016-01-12 The mixture has a ChemIDplus registry number of S900007110 (for details see: http://chem.sis.nlm.nih.gov/chemidplus/name/startswith/technivie).